Inovio Pharmaceuticals, Inc. (INO)
1.27
+0.01
(+0.79%)
USD |
NASDAQ |
May 27, 11:54
Inovio Pharmaceuticals Free Cash Flow : -83.57M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| ADMA Biologics, Inc. | 107.55M |
| Agenus, Inc. | -87.53M |
| Vaxart, Inc. | 14.80M |
| Allogene Therapeutics, Inc. | -109.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.59M |
| Cash from Investing (Quarterly) | 2.636M |
| Cash from Financing (Quarterly) | 0.9538M |
| Free Cash Flow Per Share (Quarterly) | -0.3125 |
| Free Cash Flow to Equity (Quarterly) | -20.92M |
| Free Cash Flow to Firm (Quarterly) | -21.59M |
| Free Cash Flow Yield | -114.9% |